All Stories

  1. A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection

    Article • CHEST Journal, January 2023, Elsevier

    Jin-fu Xu

  2. Necroptosis-related subtypes are associated with bronchiectasis in pulmonary non-tuberculous mycobacteria-infected patients: a perspective based on transcriptomic analysis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2022, Springer Science + Business Media

    Jin-fu Xu

  3. Advances in Bronchiectasis Registries: The New Chinese Registry

    Article • Archivos de Bronconeumología, November 2022, Elsevier

    Jin-fu Xu

  4. Pseudomonas aeruginosa Induces Interferon-β Production to Promote Intracellular Survival

    Article • Microbiology Spectrum, October 2022, ASM Journals

    Jin-fu Xu

  5. Nebulised liposomal amphotericin-B: A promising strategy for preventing ABPA relapse

    Article • European Respiratory Journal, September 2022, European Respiratory Society (ERS)

    Dr Jin-fu Xu, Jin-fu Xu

  6. Airway acidification impaired host defense against Pseudomonas aeruginosa infection by promoting type 1 interferon β response

    Article • Emerging Microbes & Infections, September 2022, Taylor & Francis

    Jin-fu Xu

  7. Advantages and challenges of metagenomic sequencing for the diagnosis of pulmonary infectious diseases

    Article • The Clinical Respiratory Journal, September 2022, Wiley

    Jin-fu Xu

  8. Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2022, Taylor & Francis

    Jin-fu Xu

  9. Editorial: T cell metabolism in infection

    Article • Frontiers in Immunology, August 2022, Frontiers

    Jin-fu Xu

  10. Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review

    Article • Orphanet Journal of Rare Diseases, July 2022, Springer Science + Business Media

    Jin-fu Xu

  11. Editorial: T Cell Metabolism in Infection

    Article • Frontiers in Immunology, July 2022, Frontiers

    Jin-fu Xu

  12. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury

    Article • Clinical Microbiology and Infection, April 2022, Elsevier

    Jin-fu Xu

  13. Research advances and clinical management of bronchiectasis: Chinese perspective

    Article • ERJ Open Research, March 2022, European Respiratory Society (ERS)

    Jin-fu Xu

  14. Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China

    Article • Emerging Microbes & Infections, February 2022, Taylor & Francis

    Jin-fu Xu

  15. Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial

    Article • Infection and Drug Resistance, February 2022, Taylor & Francis

    Jin-fu Xu

  16. Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients

    Article • The Clinical Respiratory Journal, January 2022, Wiley

    Jin-fu Xu

  17. CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis

    Article • BMC Pulmonary Medicine, January 2022, Springer Science + Business Media

    Jin-fu Xu

  18. Early predicting indicators of conversion from mild to moderate in overseas-imported COVID-19 cases

    Article • Annals of Translational Medicine, October 2021, AME Publishing Company

    Jin-fu Xu

  19. Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis

    Article • EBioMedicine, October 2021, Elsevier

    Jin-fu Xu

  20. Derivation and validation of a clinical model to identify cryptococcosis from suspected malignant pulmonary nodules: A dual‐center case‐control study

    Article • Clinical and Translational Medicine, October 2021, Wiley

    Jin-fu Xu

  21. Establishment and validation of a predictive model for nontuberculous mycobacterial infections in acid‐fast bacilli smear‐positive patients

    Article • The Clinical Respiratory Journal, August 2021, Wiley

    Jin-fu Xu

  22. The Controversy About the Effects of Different Doses of Corticosteroid Treatment on Clinical Outcomes for Acute Respiratory Distress Syndrome Patients: An Observational Study

    Article • Frontiers in Pharmacology, July 2021, Frontiers

    Jin-fu Xu

  23. RIPK3 Activates MLKL-mediated Necroptosis and Inflammasome Signaling during Streptococcus Infection

    Article • American Journal of Respiratory Cell and Molecular Biology, May 2021, American Thoracic Society

    Jin-fu Xu

  24. RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response

    Article • PLoS Pathogens, March 2021, PLOS

    Chen Wang, Jin-fu Xu

  25. Vagal-α7nAChR signaling is required for lung anti-inflammatory responses and arginase 1 expression during an influenza infection

    Article • Acta Pharmacologica Sinica, January 2021, Springer Science + Business Media

    Jin-fu Xu

  26. Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia

    Article • Annals of Translational Medicine, January 2021, AME Publishing Company

    Jin-fu Xu

  27. Candida in Lower Respiratory Tract Increases the Frequency of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Case-Control Study

    Article • Frontiers in Cellular and Infection Microbiology, September 2020, Frontiers

    Jin-fu Xu

  28. Corticosteroids alleviate lipopolysaccharide‐induced inflammation and lung injury via inhibiting NLRP3‐inflammasome activation

    Article • Journal of Cellular and Molecular Medicine, September 2020, Wiley

    Jin-fu Xu

  29. <p>Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis</p>

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2020, Taylor & Francis

    Jin-fu Xu

  30. PM2.5 compromises antiviral immunity in influenza infection by inhibiting activation of NLRP3 inflammasome and expression of interferon-β

    Article • Molecular Immunology, September 2020, Elsevier

    Jin-fu Xu

  31. Albumin-Based LL37 Peptide Nanoparticles as a Sustained Release System against Pseudomonas aeruginosa Lung Infection

    Article • ACS Biomaterials Science & Engineering, August 2020, American Chemical Society (ACS)

    Jin-fu Xu

  32. Association between age and clinical characteristics and outcomes of COVID-19

    Article • European Respiratory Journal, April 2020, European Respiratory Society (ERS)

    Jin-fu Xu

  33. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients

    Article • March 2020, Research Square

    Jin-fu Xu

  34. Response to: Comment on “Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis”

    Article • Mediators of Inflammation, March 2019, Hindawi Publishing Corporation

    Dr Jin-fu Xu, Jin-fu Xu

  35. Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis

    Article • The Clinical Respiratory Journal, August 2018, Wiley

    Dr Jin-fu Xu, Jin-fu Xu

  36. CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses

    Article • Nature Immunology, May 2018, Springer Science + Business Media

    Jin-fu Xu

  37. Dectin-3 recognizes cryptococcal glucuronoxylomannan to initiate host defense against cryptococcosis

    Article • March 2018, Cold Spring Harbor Laboratory Press

    Jin-fu Xu

  38. Pseudomonas aeruginosaisolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study

    Article • BMJ Open, March 2018, BMJ

    Jin-fu Xu

  39. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study

    Article • BMC Pulmonary Medicine, January 2018, Springer Science + Business Media

    Jin-fu Xu

  40. Smoking cessation affects the natural history of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2017, Dove Medical Press

    Dr Jin-fu Xu, Jin-fu Xu

  41. Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes

    Article • AJP Lung Cellular and Molecular Physiology, October 2017, American Physiological Society

    Jin-fu Xu

  42. Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis

    Article • Mediators of Inflammation, January 2017, Hindawi Publishing Corporation

    Dr Jin-fu Xu, Jin-fu Xu

  43. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature

    Article • Respiratory Medicine, January 2017, Elsevier

    Jin-fu Xu

  44. E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor–mediated antifungal innate immunity

    Article • The Journal of Experimental Medicine, July 2016, Rockefeller University Press

    Jin-fu Xu

  45. Bronchiectasis in China

    Article • Annals of the American Thoracic Society, May 2016, American Thoracic Society

    Jin-fu Xu

  46. A New Scale to Assess the Severity and Prognosis of Pulmonary Alveolar Proteinosis

    Article • Canadian Respiratory Journal, January 2016, Hindawi Publishing Corporation

    Jin-fu Xu

  47. Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing mediastinal lymphadenectasis: a cohort study from a single center

    Article • The Clinical Respiratory Journal, May 2015, Wiley

    Jin-fu Xu